Literature DB >> 24973878

Zinc finger nuclease: a new approach for excising HIV-1 proviral DNA from infected human T cells.

Xiying Qu1, Pengfei Wang, Donglin Ding, Xiaohui Wang, Gongmin Zhang, Xin Zhou, Lin Liu, Xiaoli Zhu, Hanxian Zeng, Huanzhang Zhu.   

Abstract

A major reason that Acquired Immune Deficiency Syndrome (AIDS) cannot be completely cured is the human immunodeficiency virus 1 (HIV-1) provirus integrated into the human genome. Though existing therapies can inhibit replication of HIV-1, they cannot eradicate it. A molecular therapy gains popularity due to its specifically targeting to HIV-1 infected cells and effectively removing the HIV-1, regardless of viral genes being active or dormant. Now, we propose a new method which can excellently delete the HIV provirus from the infected human T cell genome. First, we designed zinc-finger nucleases (ZFNs) that target a sequence within the long terminal repeat (LTR) U3 region that is highly conserved in whole clade. Then, we screened out one pair of ZFN and named it as ZFN-U3. We discovered that ZFN-U3 can exactly target and eliminate the full-length HIV-1 proviral DNA after the infected human cell lines treated with it, and the frequency of its excision was about 30 % without cytotoxicity. These results prove that ZFN-U3 can efficiently excise integrated HIV-1 from the human genome in infected cells. This method to delete full length HIV-1 in human genome can therefore provide a novel approach to cure HIV-infected individuals in the future.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24973878     DOI: 10.1007/s11033-014-3456-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  35 in total

Review 1.  The challenge of finding a cure for HIV infection.

Authors:  Douglas D Richman; David M Margolis; Martin Delaney; Warner C Greene; Daria Hazuda; Roger J Pomerantz
Journal:  Science       Date:  2009-03-06       Impact factor: 47.728

Review 2.  Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs.

Authors:  Christine Katlama; Steven G Deeks; Brigitte Autran; Javier Martinez-Picado; Jan van Lunzen; Christine Rouzioux; Michael Miller; Stefano Vella; Joern E Schmitz; Jeffrey Ahlers; Douglas D Richman; Rafick P Sekaly
Journal:  Lancet       Date:  2013-03-29       Impact factor: 79.321

3.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases.

Authors:  Fyodor D Urnov; Jeffrey C Miller; Ya-Li Lee; Christian M Beausejour; Jeremy M Rock; Sheldon Augustus; Andrew C Jamieson; Matthew H Porteus; Philip D Gregory; Michael C Holmes
Journal:  Nature       Date:  2005-04-03       Impact factor: 49.962

5.  A novel therapeutic molecule against HTLV-1 infection targeting provirus.

Authors:  A Tanaka; S Takeda; R Kariya; K Matsuda; E Urano; S Okada; J Komano
Journal:  Leukemia       Date:  2013-02-15       Impact factor: 11.528

6.  Zinc-finger nuclease-mediated targeted insertion of reporter genes for quantitative imaging of gene expression in sea urchin embryos.

Authors:  Hiroshi Ochiai; Naoaki Sakamoto; Kazumasa Fujita; Masatoshi Nishikawa; Ken-ichi Suzuki; Shinya Matsuura; Tatsuo Miyamoto; Tetsushi Sakuma; Tatsuo Shibata; Takashi Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

7.  Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.

Authors:  Nathalia Holt; Jianbin Wang; Kenneth Kim; Geoffrey Friedman; Xingchao Wang; Vanessa Taupin; Gay M Crooks; Donald B Kohn; Philip D Gregory; Michael C Holmes; Paula M Cannon
Journal:  Nat Biotechnol       Date:  2010-07-02       Impact factor: 54.908

8.  A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.

Authors:  Claudio Mussolino; Robert Morbitzer; Fabienne Lütge; Nadine Dannemann; Thomas Lahaye; Toni Cathomen
Journal:  Nucleic Acids Res       Date:  2011-08-03       Impact factor: 16.971

9.  Efficient targeted mutagenesis in the monarch butterfly using zinc-finger nucleases.

Authors:  Christine Merlin; Lauren E Beaver; Orley R Taylor; Scot A Wolfe; Steven M Reppert
Journal:  Genome Res       Date:  2012-09-25       Impact factor: 9.043

Review 10.  Lost in transcription: molecular mechanisms that control HIV latency.

Authors:  Ran Taube; Matija Peterlin
Journal:  Viruses       Date:  2013-03-21       Impact factor: 5.048

View more
  7 in total

Review 1.  Novel AIDS therapies based on gene editing.

Authors:  Kamel Khalili; Martyn K White; Jeffrey M Jacobson
Journal:  Cell Mol Life Sci       Date:  2017-02-16       Impact factor: 9.261

2.  Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy.

Authors:  Harshana S De Silva Feelixge; Daniel Stone; Harlan L Pietz; Pavitra Roychoudhury; Alex L Greninger; Joshua T Schiffer; Martine Aubert; Keith R Jerome
Journal:  Antiviral Res       Date:  2015-12-22       Impact factor: 5.970

Review 3.  Genome editing strategies: potential tools for eradicating HIV-1/AIDS.

Authors:  Kamel Khalili; Rafal Kaminski; Jennifer Gordon; Laura Cosentino; Wenhui Hu
Journal:  J Neurovirol       Date:  2015-02-26       Impact factor: 2.643

Review 4.  Advancements in Developing Strategies for Sterilizing and Functional HIV Cures.

Authors:  Wei Xu; Haoyang Li; Qian Wang; Chen Hua; Hanzhen Zhang; Weihua Li; Shibo Jiang; Lu Lu
Journal:  Biomed Res Int       Date:  2017-04-26       Impact factor: 3.411

Review 5.  CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing.

Authors:  Ishani Dasgupta; Terence R Flotte; Allison M Keeler
Journal:  Hum Gene Ther       Date:  2021-03       Impact factor: 4.793

6.  Zinc Finger Nuclease: A New Approach to Overcome Beta-Lactam Antibiotic Resistance.

Authors:  Mansoureh Shahbazi Dastjerdeh; Shirin Kouhpayeh; Faezeh Sabzehei; Hossein Khanahmad; Mansour Salehi; Zahra Mohammadi; Laleh Shariati; Zahra Hejazi; Parisa Rabiei; Mostafa Manian
Journal:  Jundishapur J Microbiol       Date:  2016-01-02       Impact factor: 0.747

7.  CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome.

Authors:  Ha Youn Shin; Chaochen Wang; Hye Kyung Lee; Kyung Hyun Yoo; Xianke Zeng; Tyler Kuhns; Chul Min Yang; Teresa Mohr; Chengyu Liu; Lothar Hennighausen
Journal:  Nat Commun       Date:  2017-05-31       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.